Temas de la conferencia The renowned 4th Dermatology Drug Development Summit Europe returns as the definitive industry-led conference for all administration routes, for chemistry and non-clinical researchers, through to clinical drug developers and strategic decision makers.
Bringing you fresh content covering Hidradenitis Suppurativa, Pachyonychia Congenita, Keratodermas and Neurofibromas as well as the latest advances in Atopic Dermatitis.
La Sociedad Científica Hanson Wade
Observaciones Speakers: Ayman Grada, Director - Medical Atopic Dermatitis and Dermatology Pipeline, Abbvie, Braham Shroot, Chief Scientific Officer, Palvella Therapeutics, Carlo Pincelli, Chief Medical Officer, PinCell and More.